Inclusion of salt form on prescription medication labeling as a source of patient confusion: a pilot study
Background: It has been estimated that 10,000 patient injuries occur in the US annually due to confusion involving drug names. An unexplored source of patient misunderstandings may be medication salt forms.
Objective: The objective of this study was to assess patient knowledge and comprehension regarding the salt forms of medications as a potential source of medication errors.
Methods: A 12 item questionnaire which assessed patient knowledge of medication names on prescription labels was administered to a convenience sample of patients presenting to a family practice clinic. Descriptive statistics were calculated and multivariate analyses were performed.
Results: There were 308 responses. Overall, 41% of patients agreed they find their medication names confusing. Participants correctly answered to salt form questions between 12.1% and 56.9% of the time. Taking more prescription medications and higher education level were positively associated with providing more correct answers to 3 medication salt form knowledge questions, while age was negatively associated.
Conclusions: Patient misconceptions about medication salt forms are common. These findings support recommendations to standardize the inclusion or exclusion of salt forms. Increasing patient education is another possible approach to reducing confusion.
2. Kenagy JW, Stein GC. Naming, labeling, and packaging of pharmaceuticals. Am J Health-Syst Pharm 2001;58(21):2033-2041.
3. Filik R, Purdy K, Gale A, Gerrett D. Labeling of medicines and patient safety: evaluating methods of reducing drug name confusion. Human Factors 2006;48(1):39-47.
4. Gabriele S. The role of typography in differentiating look-alike/sound-alike drug names. Healthc Q. 2006;9(Spec No):88-95.
5. McDougall DJ, Lallier TS, Hoehns JD, Friedman RL. Medication nonadherence due to misunderstanding of the salt form. Ann Pharmacother. 2014;48(1):149-150. doi: 10.1177/1060028013510150
6. Kumar L, Amin A, Bansal AK. Salt selection in drug development. PharmTech.com. 3/2/2008. http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Salt-Selection-in-Drug-Development/ArticleStandard/Article/detail/500407 (accessed May 31, 2015).
7. Paulekhun SG, Dressman JB, Saal C. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. J Med Chem. 2007;50(26):6665-6672 doi: 10.1021/jm701032y
8. Principles of designing a medication label for community and mail order pharmacy prescription packages. https://www.ismp.org/tools/guidelines/labelFormats/comments/default.asp (accessed March 19, 2015).
9. Iowa Administrative Code. Iowa Board of Pharmacy. http://www.state.ia.us/ibpe/rules_laws/ (accessed March 30, 2015).
10. Laws and Regulations. California State Board of Pharmacy. http://www.pharmacy.ca.gov/laws_regs/ (accessed March 30, 2015).
11. Laws, Rules, and Regulations. NYSED.gov Office of the Professions. http://www.op.nysed.gov/prof/pharm/pharmlaw.htm (accessed March 30, 2015).
12. Pharmacy: Rules and Laws. New Mexico Regulation and Licensing Department. http://www.rld.state.nm.us/boards/Pharmacy_Rules_and_Laws.aspx (accessed March 30, 2015).
13. Virginia Board of Pharmacy Laws and Regulations. Virginia Board of Pharmacy. https://www.dhp.virginia.gov/pharmacy /pharmacy_laws_regs.htm (accessed March 30, 2015).
14. Kremzner ME, Lal R, Stodart B. FDA application of the USP salt policy. Am J Health-Syst Pharm 2014;71(9):694-696. doi: 10.2146/ajhp130507
15. Unites States Pharmacopeia. Monograph naming policy for salt drug substances in drug products and compounded preparations. www.usp.org/usp-nf/development-process/compendial-nomenclature/monograph-naming-policy-salt-drug-substances-drug-products-and-compounded (accessed August 17, 2015).
16. Weiss BD, Mays MZ, Martz W, Castro KM, DeWalt DA, Pignone MP, Mockbee J, Hale FA. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med 2005;3(6):514-522. doi: 10.1370/afm.405